PDCD1LG2 and breast cancer: To date, only two articles have reported a native fucoidan that can decrease PD-L1 expression in tumor tissues of experimental-induced mammary cancer [22] and a LMW one that can decrease transcriptional expression of PD-L1 and PD-L2 and PD-L1 protein level in fibrosarcoma cells [23].